I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Erdem, Rahsan
49
results:
Search for persons
X
Format
Online (49)
Mediatypes
Articles (Online) (14)
OpenAccess-fulltext (35)
Languages
english (24)
Sorted by: Relevance
Sorted by: Year
?
1
Safety, tolerability, and immunogenicity of inactivated pol..:
Erdem, Rahsan
;
De Coster, Ilse
;
Withanage, Kanchanamala
...
Vaccine. 41 (2023) 10 - p. 1657-1667 , 2023
Link:
https://doi.org/10.1016/..
?
2
Safety and immunogenicity of intramuscularly administered C..:
Lee, Tida
;
Gutiérrez, Ramiro L.
;
Maciel, Milton
...
Vaccine. 39 (2021) 39 - p. 5548-5556 , 2021
Link:
https://doi.org/10.1016/..
?
3
A Phase 2a randomized, single-center, double-blind, placebo..:
Erdem, Rahsan
;
Ambler, Gwen
;
Al-Ibrahim, Mohamed
...
PLOS Neglected Tropical Diseases. 15 (2021) 11 - p. e0009969 , 2021
Link:
https://doi.org/10.1371/..
?
4
Safety, tolerability, and immunogenicity of inactivated pol..:
Erdem, Rahsan
;
De Coster, Ilse
;
Withanage, Kanchanamala
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996288/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
5
Safety and immunogenicity of intramuscularly administered C..:
Lee, Tida
;
Gutiérrez, Ramiro L
;
Maciel, Milton
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461560/. , 2021
Link:
http://www.ncbi.nlm.nih...
?
6
A Phase 2a randomized, single-center, double-blind, placebo..:
Erdem, Rahsan
;
Ambler, Gwen
;
Al-Ibrahim, Mohamed
...
PLoS Neglected Tropical Diseases. , 2021
Link:
http://hdl.handle.net/10..
?
7
A Phase 2a randomized, single-center, double-blind, placebo..:
Rahsan Erdem
;
Gwen Ambler
;
Mohamed Al-Ibrahim
...
https://doi.org/10.1371/journal.pntd.0009969. , 2021
Link:
https://doi.org/10.1371/..
?
8
Supporting information:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/journal_contribution/Supporting_information_/17045387. , 2021
Link:
https://doi.org/10.1371/..
?
9
Grading of stool consistency and diarrhea severity:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/dataset/Grading_of_stool_consistency_and_diarrhea_severity_/17045483. , 2021
Link:
https://doi.org/10.1371/..
?
10
Secondary efficacy endpoints for the modified intent-to-tre..:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/dataset/Secondary_efficacy_endpoints_for_the_modified_intent-to-treat_population_/17045501. , 2021
Link:
https://doi.org/10.1371/..
?
11
Study drug–related treatment-emergent adverse events by sys..:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/dataset/Study_drug_related_treatment-emergent_adverse_events_by_system_organ_class_and_preferred_term_in_the_safety_population_/17045492. , 2021
Link:
https://doi.org/10.1371/..
?
12
Consolidated Standards for Reporting of Trials flow diagram:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/figure/Consolidated_Standards_for_Reporting_of_Trials_flow_diagram_/17045465. , 2021
Link:
https://doi.org/10.1371/..
?
13
Cumulative diarrhea stool volume for all subjects:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/journal_contribution/Cumulative_diarrhea_stool_volume_for_all_subjects_/17045414. , 2021
Link:
https://doi.org/10.1371/..
?
14
Source data for Fig 1:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/dataset/Source_data_for_Fig_1_/17045438. , 2021
Link:
https://doi.org/10.1371/..
?
15
Treatment-emergent adverse events by preferred term reporte..:
Rahsan Erdem (11726357)
;
Gwen Ambler (476523)
;
Mohamed Al-Ibrahim (11726360)
...
https://figshare.com/articles/journal_contribution/Treatment-emergent_adverse_events_by_preferred_term_reported_in_more_than_one_participant_5_in_any_treatment_group_in_the_safety_population_/17045408. , 2021
Link:
https://doi.org/10.1371/..
1-15
